These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 29922886)
1. Evaluation of Serum Paired MicroRNA Ratios for Differential Diagnosis of Non-Small Cell Lung Cancer and Benign Pulmonary Diseases. Fan L; Sha J; Teng J; Li D; Wang C; Xia Q; Chen H; Su B; Qi H Mol Diagn Ther; 2018 Aug; 22(4):493-502. PubMed ID: 29922886 [TBL] [Abstract][Full Text] [Related]
2. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
3. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related]
4. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients. Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532 [TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
6. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
8. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
9. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer. Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397 [No Abstract] [Full Text] [Related]
10. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Wang RJ; Zheng YH; Wang P; Zhang JZ Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772 [TBL] [Abstract][Full Text] [Related]
11. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
12. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis. Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822 [TBL] [Abstract][Full Text] [Related]
13. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer. Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767 [TBL] [Abstract][Full Text] [Related]
14. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
15. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
16. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Dong X; Chang M; Song X; Ding S; Xie L; Song X Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399 [TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients. Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study. Ĺwitlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648 [No Abstract] [Full Text] [Related]
19. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
20. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]